Planimetric hematoma measurement in patients with intraventricular hemorrhage: Is total volume a preferred target for reliable analysis?

Stroke

Volumn 43, Issue 7, 2012, Pages 1961-1963

  Dowlatshahi, Dar ^a   Kosior, Jayme C ^b,c   Idris, Sherif ^b   Eesa, Muneer ^b,c,d   Dickhoff, Peter ^d   Joshi, Manish ^a   Subramaniam, Suresh ^b,d   Tymchuk, Sarah ^b   Hill, Michael D ^b,c,d,e   Aviv, Richard I ^f   Frayne, Richard ^b,c,d   Demchuk, Andrew M ^b,c,d  

^a UNIVERSITY OF OTTAWA   (Canada)

^b FOOTHILLS HOSPITAL   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

^f SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

intracerebral hemorrhage; intraventricular hemorrhage; planimetry

Indexed keywords

ARTICLE; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN VENTRICLE; CLINICAL ARTICLE; COMPUTER ANALYSIS; COMPUTER ASSISTED PLANIMETRY; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; HUMAN; MEASUREMENT; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PLANIMETRY; PRIORITY JOURNAL; RELIABILITY; SCORING SYSTEM;

CEREBRAL HEMORRHAGE; CONE-BEAM COMPUTED TOMOGRAPHY; HEMATOMA, EPIDURAL, CRANIAL; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; PROGNOSIS; SINGLE-BLIND METHOD;

EID: 84863317287     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.654970     Document Type: Article

References (10)

1. Davis SM, Broderick J, Hennerici M, Brun NC, Diringer MN, Mayer SA, et al. Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology. 2006;66:1175-1181. (Pubitemid 43739699)
2. Steiner T, Diringer MN, Schneider D, Mayer SA, Begtrup K, Broderick J, et al. Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery. 2006;59: 767-773. (Pubitemid 44579589)
3. Hallevi H, Albright KC, Aronowski J, Barreto AD, Martin-Schild S, Khaja AM, et al. Intraventricular hemorrhage: Anatomic relationships and clinical implications. Neurology. 2008;70:848-852. (Pubitemid 351367505)
4. Anderson CS, Huang Y, Wang JG, Arima H, Neal B, Peng B, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008;7:391-399.
5. Kosior JC, Idris S, Dowlatshahi D, Alzawahmah M, Eesa M, Sharma P, et al. Quantomo: validation of a computer-assisted methodology for the volumetric analysis of intracerebral hemorrhage. Int J Stroke. 2011;6: 302-305.
6. Demchuk AM, Kosior J, Tymchuk S, Molina C, Dzialowski I, Boulanger JM, et al. Multicentre prospective study demonstrates validity of CTA spot sign for hematoma expansion prediction in noncoagulopathic primary ICH patients (Abstract). Cerebrovasc Dis. 2008;25(Suppl 2):52.
7. Eliasziw M, Young SL, Woodbury MG, Fryday-Field K. Statistical methodology for the concurrent assessment of interrater and intrarater reliability: using goniometric measurements as an example. Phys Ther. 1994;74:777-788. (Pubitemid 24245119)
8. Hallevi H, Dar NS, Barreto AD, Morales MM, Martin-Schild S, Abraham AT, et al. The IVH score: A novel tool for estimating intraventricular hemorrhage volume. Crit Care Med. 2009;37:969-974.
9. Turner D, Schünemann HJ, Griffith LE, Beaton DE, Griffiths AM, Critch JN, et al. The minimal detectable change cannot reliably replace the minimal important difference. J Clin Epidemiol. 2010;63:28-36.
10. Dowlatshahi D, Demchuk AM, Flaherty ML, Ali M, Lyden PL, Smith EE. Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes. Neurology. 2011;76:1238-1244.